GlassScriptPhysician profile
Zaw Win Tun
NPI 1205242096
$52,024.79
in general payments reported to CMS, 2019-2025
34 companies · $4,185 in 2025
The $4,185 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,543 · 2020: $4,476 · 2021: $4,489 · 2022: $18K · 2023: $14K · 2024: $2,179 · 2025: $4,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $8,902 · Education: $328 · Entertainment: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,079.81 |
| Food and Beverage | $8,902.34 |
| Education | $328.24 |
| Entertainment | $173.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,333.16 | 2021-2025 | Micra, Diamondtemp Bidirectional Ablation Catheter, Arctic Front Advance |
| Biotronik INC. | $12,648.23 | 2019-2025 | Biomonitor, Edora 8 Dr-T, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $6,274.13 | 2019-2025 | Ensite, Ensite Precision, Advisor |
| Boston Scientific Corporation | $5,725.04 | 2021-2025 | Watchman Flx, Endotak Reliance S, Lux-Dx Insertable Cardiac Monitor |
| Medical Device Business Services, INC. | $3,142.94 | 2022-2023 | Carto 3 |
| Stereotaxis INC | $1,857.47 | 2021-2024 | Niobe, Genesis |
| Baylis Medical Company INC | $1,053.28 | 2019-2021 | |
| Biosense Webster, INC. | $780.13 | 2021-2023 | Carto 3, Octaray Mapping Catheter |
| Cardiva Medical, INC. | $704.76 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Medtronic Vascular, INC. | $327.38 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $293.58 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $277.58 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $255.10 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $197.71 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $150.21 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $143.02 | 2021-2023 | |
| Edwards Lifesciences Corporation | $124.99 | 2019 | |
| Cardiovascular Systems INC. | $122.60 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $106.11 | 2019 | |
| Astellas Pharma US INC | $99.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $60.56 | 2024-2025 | Camzyos, Eliquis |
| Baxter Healthcare | $47.98 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Altathera Pharmaceuticals LLC | $40.76 | 2024-2025 | Sotalol Hydrochloride |
| Medicomp INC | $36.81 | 2025 | Telepatch Cardiac Monitor |
| Acist Medical Systems, INC. | $33.47 | 2025 | |
| Atricure, INC. | $33.39 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Actelion Pharmaceuticals US, INC. | $29.45 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.27 | 2020 | |
| Philips North America LLC | $20.83 | 2023 | |
| Impulse Dynamics (USA) INC. | $19.90 | 2025 | Optimizer |
| Bridgebio Pharma, INC. | $18.40 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $16.64 | 2024 | Verquvo |
| Pfizer INC. | $13.90 | 2024 | |
| Amgen INC. | $13.02 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaw Win Tun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.